• 1
    Marseille Consensus Group. Classification of progressive myoclonus epilepsies and related disorders. Consensus statement, American Neurological Association. Ann Neurol 1990;28:1136.
  • 2
    Lehesjoki AE, Koskiniemi M, Sistonen P, et al. Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Genetics 1991;88:36969.
  • 3
    Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:17314.
  • 4
    Iivanainen M, Himberg JJ. Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy. Arch Neurol 1982;39:2368.
  • 5
    Koskiniemi M, Van Vleymen B, Hakamies L, Lamusuo S, Taalas J. Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 1998;64:3448.
  • 6
    Henry TR, Leppik IE, Gumnit RJ, Jacobs M. Progressive myoclonus epilepsy treated with zonisamide. Neurology 1988;38:92831.
  • 7
    Awaad Y, Fish I. Baclofen in the treatment of polymyoclonus in a patient with Unverricht-Lundborg disease. J Child Neurol 1995;10:6870.
  • 8
    Hurd RW, Wilder BJ, Helveston WR, Uthman BM. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine, Neurology 1996;47:12648.
  • 9
    Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures. Neurology 1998;51:4855.
  • 10
    Labar D, Nikolov B, Tarver B, Fraser R. Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia 1998;39:2015.
  • 11
    McLachlan RS. Vagus nerve stimulation for intractable epilepsy. J Clin Neurophysiol 1997;14:35868.